Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment.
Luksch R, Podda M, Gandola L, Polastri D, Piva L, Castellani R, Collini P, Massimino M, Cefalo G, Terenziani M, Ferrari A, Casanova M, Spreafico F, Meazza C, Bozzi F, Marchianò A, Ravagnani F, Fossati-Bellani F. Luksch R, et al. Among authors: ravagnani f. Br J Cancer. 2005 Jun 6;92(11):1984-8. doi: 10.1038/sj.bjc.6602615. Br J Cancer. 2005. PMID: 15900298 Free PMC article. Clinical Trial.
Immunomodulation in a treatment program including pre- and post-operative interleukin-2 and chemotherapy for childhood osteosarcoma.
Luksch R, Perotti D, Cefalo G, Gambacorti Passerini C, Massimino M, Spreafico F, Casanova M, Ferrari A, Terenziani M, Polastri D, Gambirasio F, Podda M, Bozzi F, Ravagnani F, Parmiani G, Fossati Bellani F. Luksch R, et al. Among authors: ravagnani f. Tumori. 2003 May-Jun;89(3):263-8. doi: 10.1177/030089160308900306. Tumori. 2003. PMID: 12908780
Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin 2: possible role for lymphokine-activated killer cell infusion in the in vivo-induced activation.
Gambacorti-Passerini C, Rivoltini L, Radrizzani M, Belli F, Sciorelli G, Ravagnani F, Galazka AR, Cascinelli N, Parmiani G. Gambacorti-Passerini C, et al. Among authors: ravagnani f. Cancer Res. 1989 Sep 15;49(18):5230-4. Cancer Res. 1989. PMID: 2788498
Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.
Farina L, Guidetti A, Spina F, Roncari L, Longoni P, Ravagnani F, Carlo-Stella C, Corradini P. Farina L, et al. Among authors: ravagnani f. Bone Marrow Transplant. 2014 Mar;49(3):453-5. doi: 10.1038/bmt.2013.193. Epub 2013 Dec 9. Bone Marrow Transplant. 2014. PMID: 24317127 No abstract available.
104 results